Complementarily, pharmacological blockade of AQP4 right after stroke has shown protective effects; treating mice with the AQP4 inhibitor TGN-020 within 1 h of MCAO decreased brain swelling at 24 h and improved long-term functional recovery [19,21]. This evidence concerns the gene AQP4 and stroke disorder.